AstraZeneca Seeks To Halt Looming Diabetes Drug Generics
By Alex Baldwin ( May 14, 2025, 10:01 PM BST) -- AstraZeneca has asked an English court to block several generic-drug makers from imminently releasing variants of its billion-dollar diabetes treatment dapagliflozin ahead of a long-awaited judgment determining the validity of remaining patent protections for the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.